Lineage Cell Therapeutics
LCTX
#8221
Rank
S$0.21 B
Marketcap
$1.12
Share price
1.22%
Change (1 day)
-36.01%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Cash on Hand

Cash on Hand as of June 2024 : S$50.22 M

According to Lineage Cell Therapeutics 's latest financial reports the company has S$50.22 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lineage Cell Therapeutics - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$46.87 M-39.59%
2022-12-31S$77.58 M-1.66%
2021-12-31S$78.89 M43.49%
2020-12-31S$54.98 M32.78%
2019-12-31S$41.41 M-1.4%
2018-12-31S$41.99 M-17.75%
2017-12-31S$51.05 M55.31%
2016-12-31S$32.87 M-45.93%
2015-12-31S$60.79 M56.03%
2014-12-31S$38.96 M459.65%
2013-12-31S$6.96 M30.89%
2012-12-31S$5.31 M-81.51%
2011-12-31S$28.76 M-32.99%
2010-12-31S$42.92 M150.85%
2009-12-31S$17.11 M97349.08%
2008-12-31S$0.01 M28.44%
2007-12-31S$0.01 M-98.41%
2006-12-31S$0.86 M-71.82%
2005-12-31S$3.05 M36.53%
2004-12-31S$2.23 M83.53%
2003-12-31S$1.21 M-45.33%
2002-12-31S$2.22 M-27.16%
2001-12-31S$3.05 M33.91%
2000-12-31S$2.28 M-74.07%
1999-12-31S$8.81 M122.4%
1998-12-31S$3.96 M
1998-06-30S$6.9 M-38.11%
1997-06-30S$11.15 M229.31%
1996-06-30S$3.38 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.37 B 643.99%๐Ÿ‡บ๐Ÿ‡ธ USA